Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2-(4-ethyl-4,5-dihydro-5-oxo1h-tetrazolyl)ethyl)-3-methyl-4-(n-(2-fluorophenyl)methoxyacetamido)piperidine
2. A 3331
3. A-3331
4. A-3331.hcl
5. Brifentanil Hydrochloride
1. Brifentanil [inn]
2. 101345-71-5
3. 6gdt77pqbw
4. N-[(3r,4s)-1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-3-methylpiperidin-4-yl]-n-(2-fluorophenyl)-2-methoxyacetamide
5. Brifentanilum
6. Brifentanyl
7. N-[(3s,4r)-1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-3-methylpiperidin-4-yl]-n-(2-fluorophenyl)-2-methoxyacetamide
8. Brifentanilo
9. Unii-6gdt77pqbw
10. Brifentanilum [inn-latin]
11. Brifentanilo [inn-spanish]
12. A-3331-
13. Brifentanil [who-dd]
14. Schembl488879
15. Dtxsid20143867
16. Db09172
17. Q4967117
18. (+/-)-cis-n-(1-(2-(4-ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-3-methyl-4-piperidyl)-2'-fluoro-2-methoxyacetanilide
19. Acetamide, N-((3r,4s)-1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-3-methyl-4-piperidinyl)-n-(2-fluorophenyl)-2-methoxy-, Rel-
20. Acetamide, N-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-3-methyl-4-piperidinyl)-n-(2-fluorophenyl)-2-methoxy-, Cis-
21. Acetamide, N-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-3-methyl-4-piperidinyl)-n-(2-fluorophenyl)-2-methoxy-, Cis-(+/-)-
| Molecular Weight | 420.5 g/mol |
|---|---|
| Molecular Formula | C20H29FN6O3 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 420.22851697 g/mol |
| Monoisotopic Mass | 420.22851697 g/mol |
| Topological Polar Surface Area | 81 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 636 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
37
PharmaCompass offers a list of Brifentanil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brifentanil manufacturer or Brifentanil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brifentanil manufacturer or Brifentanil supplier.
PharmaCompass also assists you with knowing the Brifentanil API Price utilized in the formulation of products. Brifentanil API Price is not always fixed or binding as the Brifentanil Price is obtained through a variety of data sources. The Brifentanil Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Brifentanil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brifentanil, including repackagers and relabelers. The FDA regulates Brifentanil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brifentanil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Brifentanil supplier is an individual or a company that provides Brifentanil active pharmaceutical ingredient (API) or Brifentanil finished formulations upon request. The Brifentanil suppliers may include Brifentanil API manufacturers, exporters, distributors and traders.
Brifentanil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brifentanil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brifentanil GMP manufacturer or Brifentanil GMP API supplier for your needs.
A Brifentanil CoA (Certificate of Analysis) is a formal document that attests to Brifentanil's compliance with Brifentanil specifications and serves as a tool for batch-level quality control.
Brifentanil CoA mostly includes findings from lab analyses of a specific batch. For each Brifentanil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brifentanil may be tested according to a variety of international standards, such as European Pharmacopoeia (Brifentanil EP), Brifentanil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brifentanil USP).
